Literature DB >> 10999441

Effects of berberine on arylamine N-acetyltransferase activity and 2-aminofluorene-DNA adduct formation in human leukemia cells.

J G Chung1, G W Chen, C F Hung, J H Lee, C C Ho, H C Ho, H L Chang, W C Lin, J G Lin.   

Abstract

Berberine is an alkaloid occurring in the plant genera Berberis and Coptis. Although berberine had been demonstrated to have antineoplastic function by inhibiting DNA-synthesis in activated lymphocytes, there is no available information to address berberine affects on human leukemia cell N-acetyltransferase (NAT) activity and 2-aminofluorene (AF)-DNA adduct formation. Thus, berberine was tested for inhibition of arylamine NAT activity and AF-DNA adduct formation in human leukemia cells. The NAT activity was measured by a high performance liquid chromatography assaying for the amounts of N-acetyl-2-aminofluorene (AAF) and N-acetyl-p-aminobenzoic acid (N-Ac-PABA) and the remaining AF and p-aminobenzoic acid (PABA). The NAT activity and AF-DNA adduct formation in human leukemia cells were inhibited by berberine in a dose-dependent manner, i.e. the higher the concentration of berberine, the higher the inhibition of NAT activity and AF-DNA adduct. The data also indicate that berberine decreased the apparent values of Km and Vmax from human leukemia cells in both cytosol and intact cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10999441     DOI: 10.1142/S0192415X00000271

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  4 in total

1.  Berberine inhibited arylamine N-acetyltransferase activity and gene expression and DNA adduct formation in human malignant astrocytoma (G9T/VGH) and brain glioblastoma multiforms (GBM 8401) cells.

Authors:  D Y Wang; C C Yeh; J H Lee; C F Hung; J G Chung
Journal:  Neurochem Res       Date:  2002-09       Impact factor: 3.996

2.  In vitro biological assessment of Berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects.

Authors:  Abeer E Abd El-Wahab; Doaa A Ghareeb; Eman E M Sarhan; Marwa M Abu-Serie; Maha A El Demellawy
Journal:  BMC Complement Altern Med       Date:  2013-09-05       Impact factor: 3.659

3.  Berberine-induced autophagic cell death by elevating GRP78 levels in cancer cells.

Authors:  Xiaoqin La; Lichao Zhang; Zhuoyu Li; Peng Yang; Yingying Wang
Journal:  Oncotarget       Date:  2017-03-28

4.  Interaction of herbal compounds with biological targets: a case study with berberine.

Authors:  Xiao-Wu Chen; Yuan Ming Di; Jian Zhang; Zhi-Wei Zhou; Chun Guang Li; Shu-Feng Zhou
Journal:  ScientificWorldJournal       Date:  2012-11-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.